Efficacy of Lactobacillus Reuteri Protectis on Functional Abdominal Pain (FAP) in Children 8-14 Years Old (LactoFAP)
Sponsor: BioGaia AB
Terminated
The recruitment rate was too slow according to study protocol and agreement.
Other terminated trials from BioGaia AB
More terminations from BioGaia AB
Other Abdominal Pain trials with similar outcome
A NA clinical study on Abdominal Pain, this trial is terminated or withdrawn. The trial is conducted by BioGaia AB and has accumulated 7 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Sep 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2021 — Sep 2021 [monthly]
Terminated NA
Phase: PHASE4 → NA
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BioGaia AB
- Sprim CRO, Italia
For direct contact, visit the study record on ClinicalTrials.gov .